Checkpoint Therapeutics Inc
NASDAQ:CKPT
Checkpoint Therapeutics Inc
NASDAQ:CKPT
Price:
4.26
USD
0.71%
Market Closed
Market Cap:
$370.7m
Balance Sheet
Balance Sheet Decomposition
Checkpoint Therapeutics Inc
Checkpoint Therapeutics Inc
Balance Sheet Decomposition is not available for
Checkpoint Therapeutics Inc
Checkpoint Therapeutics Inc
Balance Sheet
Checkpoint Therapeutics Inc
Checkpoint Therapeutics Inc
Currency: USD
| Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
50
|
35
|
19
|
22
|
26
|
41
|
55
|
12
|
5
|
7
|
|
| Cash Equivalents |
50
|
35
|
19
|
22
|
26
|
41
|
55
|
12
|
5
|
7
|
|
| Total Receivables |
0
|
1
|
0
|
2
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Assets |
0
|
0
|
2
|
1
|
1
|
2
|
1
|
1
|
0
|
1
|
|
| Total Current Assets |
51
|
36
|
21
|
25
|
27
|
43
|
56
|
13
|
5
|
7
|
|
| Total Assets |
51
N/A
|
36
-29%
|
21
-40%
|
25
+16%
|
27
+8%
|
43
+58%
|
56
+31%
|
13
-76%
|
5
-60%
|
7
+39%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
1
|
3
|
4
|
11
|
4
|
4
|
17
|
13
|
9
|
9
|
|
| Accrued Liabilities |
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
2
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
0
|
1
|
2
|
2
|
4
|
2
|
8
|
19
|
8
|
10
|
|
| Total Current Liabilities |
2
|
4
|
6
|
13
|
8
|
7
|
26
|
33
|
18
|
20
|
|
| Long-Term Debt |
2
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Liabilities |
4
N/A
|
4
-14%
|
6
+74%
|
13
+105%
|
8
-38%
|
7
-11%
|
26
+260%
|
33
+26%
|
18
-44%
|
20
+9%
|
|
| Equity | |||||||||||
| Common Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
14
|
36
|
59
|
95
|
120
|
143
|
200
|
262
|
314
|
371
|
|
| Additional Paid In Capital |
60
|
69
|
74
|
107
|
139
|
179
|
230
|
243
|
301
|
358
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
46
N/A
|
32
-30%
|
15
-53%
|
12
-21%
|
19
+60%
|
35
+88%
|
30
-16%
|
19
N/A
|
13
+33%
|
13
+3%
|
|
| Total Liabilities & Equity |
51
N/A
|
36
-29%
|
21
-40%
|
25
+16%
|
27
+8%
|
43
+58%
|
56
+31%
|
13
-76%
|
5
-60%
|
7
+39%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
9
|
9
|
9
|
10
|
12
|
13
|
15
|
10
|
28
|
54
|
|
Switch to:
Switch to:
See Also
Discover More
